Alembic Pharmaceuticals Limited (NSE: APLLTD)

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 16.48B INR in the quarter ending September 30, 2024, with 3.33% growth. This brings the company's revenue in the last twelve months to 63.57B, up 6.02% year-over-year. In the fiscal year ending March 31, 2024, Alembic Pharmaceuticals had annual revenue of 62.29B with 10.19% growth.

• Revenue (ttm): 63.57B
• Revenue Growth: +6.02%
• P/S Ratio: 3.22
• Revenue / Employee: 4.28M
• Employees: 14,858
• Market Cap: 204.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	62.29B	5.76B	10.19%
Mar 31, 2023	56.53B	3.47B	6.54%
Mar 31, 2022	53.06B	-873.40M	-1.62%
Mar 31, 2021	53.93B	7.87B	17.10%
Mar 31, 2020	46.06B	6.71B	17.06%